NF-YA promotes invasion and angiogenesis by upregulating EZH2-STAT3 signaling in human melanoma cells
The process of angiogenesis is essential for tumor development and metastasis. Vascular endothelial growth factor (VEGF), which is overexpressed in most human cancers, has been demonstrated to be a major modulator of angiogenesis. Thus, inhibition of VEGF signaling has the potential for tumor anti-a...
Saved in:
Published in | Oncology reports Vol. 35; no. 6; pp. 3630 - 3638 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Greece
D.A. Spandidos
01.06.2016
Spandidos Publications Spandidos Publications UK Ltd |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The process of angiogenesis is essential for tumor development and metastasis. Vascular endothelial growth factor (VEGF), which is overexpressed in most human cancers, has been demonstrated to be a major modulator of angiogenesis. Thus, inhibition of VEGF signaling has the potential for tumor anti-angiogenic therapy. Signal transducer and activator of transcription-3 (STAT3) is a key regulator for angiogenesis by directly binding to the VEGF promoter to upregulate its transcription. Several factors can enhance STAT3 activity to affect angiogenesis. Here, we found that overexpression of nuclear transcription factor-Y alpha (NF-YA) gene could promote cell invasion and angiogenesis accompanying the increase of STAT3 signaling in human melanoma cells. Moreover, the expression and secretion of VEGF was also found to be upregulated by the overexpression of NF-YA gene in melanoma cells. The STAT3 inhibitor was able to attenuate the upregulation of VEGF induced by NF-YA overexpression. Enhancer of zeste homolog 2 (EZH2), the catalytic subunit of the Polycomb repressive complex 2, enhances STAT3 activity by mediating its lysine methylation. We also showed that NF-YA upregulated the expression of EZH2 and NF-YA-induced angiogenesis could be inhibited by EZH2 knockdown. Taken together, these findings indicate that overexpression of NF-YA contributes to tumor angiogenesis through EZH2-STAT3 signaling in human melanoma cells, highlighting NF-YA as a potential therapeutic target in human melanoma. |
---|---|
AbstractList | The process of angiogenesis is essential for tumor development and metastasis. Vascular endothelial growth factor (VEGF), which is overexpressed in most human cancers, has been demonstrated to be a major modulator of angiogenesis. Thus, inhibition of VEGF signaling has the potential for tumor anti-angiogenic therapy. Signal transducer and activator of transcription-3 (STAT3) is a key regulator for angiogenesis by directly binding to the VEGF promoter to upregulate its transcription. Several factors can enhance STAT3 activity to affect angiogenesis. Here, we found that overexpression of nuclear transcription factor-Y alpha (NF-YA) gene could promote cell invasion and angiogenesis accompanying the increase of STAT3 signaling in human melanoma cells. Moreover, the expression and secretion of VEGF was also found to be upregulated by the overexpression of NF-YA gene in melanoma cells. The STAT3 inhibitor was able to attenuate the upregulation of VEGF induced by NF-YA overexpression. Enhancer of zeste homolog 2 (EZH2), the catalytic subunit of the Polycomb repressive complex 2, enhances STAT3 activity by mediating its lysine methylation. We also showed that NF-YA upregulated the expression of EZH2 and NF-YA‑induced angiogenesis could be inhibited by EZH2 knockdown. Taken together, these findings indicate that overexpression of NF-YA contributes to tumor angiogenesis through EZH2-STAT3 signaling in human melanoma cells, highlighting NF-YA as a potential therapeutic target in human melanoma. The process of angiogenesis is essential for tumor development and metastasis. Vascular endothelial growth factor (VEGF), which is overexpressed in most human cancers, has been demonstrated to be a major modulator of angiogenesis. Thus, inhibition of VEGF signaling has the potential for tumor anti-angiogenic therapy. Signal transducer and activator of transcription-3 (STAT3) is a key regulator for angiogenesis by directly binding to the VEGF promoter to upregulate its transcription. Several factors can enhance STAT3 activity to affect angiogenesis. Here, we found that overexpression of nuclear transcription factor-Y alpha (NF-YA) gene could promote cell invasion and angiogenesis accompanying the increase of STAT3 signaling in human melanoma cells. Moreover, the expression and secretion of VEGF was also found to be upregulated by the overexpression of NF-YA gene in melanoma cells. The STAT3 inhibitor was able to attenuate the upregulation of VEGF induced by NF-YA overexpression. Enhancer of zeste homolog 2 (EZH2), the catalytic subunit of the Polycomb repressive complex 2, enhances STAT3 activity by mediating its lysine methylation. We also showed that NF-YA upregulated the expression of EZH2 and NF-YA-induced angiogenesis could be inhibited by EZH2 knockdown. Taken together, these findings indicate that overexpression of NF-YA contributes to tumor angiogenesis through EZH2-STAT3 signaling in human melanoma cells, highlighting NF-YA as a potential therapeutic target in human melanoma. |
Audience | Academic |
Author | WANG, BENFENG QIN, GAOPING ZHANG, ZHENXIN MU, SHENGZHI FAN, RONGHUI XU, ZIHAN WANG, GUODONG SUN, YAOWEN GAO, WENJIE GUO, YADONG WU, HANGLI |
Author_xml | – sequence: 1 givenname: ZIHAN surname: XU fullname: XU, ZIHAN – sequence: 2 givenname: YAOWEN surname: SUN fullname: SUN, YAOWEN – sequence: 3 givenname: YADONG surname: GUO fullname: GUO, YADONG – sequence: 4 givenname: GAOPING surname: QIN fullname: QIN, GAOPING – sequence: 5 givenname: SHENGZHI surname: MU fullname: MU, SHENGZHI – sequence: 6 givenname: RONGHUI surname: FAN fullname: FAN, RONGHUI – sequence: 7 givenname: BENFENG surname: WANG fullname: WANG, BENFENG – sequence: 8 givenname: WENJIE surname: GAO fullname: GAO, WENJIE – sequence: 9 givenname: HANGLI surname: WU fullname: WU, HANGLI – sequence: 10 givenname: GUODONG surname: WANG fullname: WANG, GUODONG – sequence: 11 givenname: ZHENXIN surname: ZHANG fullname: ZHANG, ZHENXIN |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27109360$$D View this record in MEDLINE/PubMed |
BookMark | eNptkcFrFDEUxoNUbLt68ywDgngwa5I3k8kcl9JaoejBFdRLyM68zKbMJGsyI_S_N0Nra0VCSHj8vvfy5TslRz54JOQlZ2tQjXgf4lowLtdlLfkTcsLrhlNRAj_KdyY4Bai-HZPTlK4ZEzWTzTNyLGrOGpDshOCnC_p9UxxiGMOEqXD-l0ku-ML4Lu_ehR49JpeK3U0xHyL282Am5_vi_MeloF-2my0UyfXeDEvR-WI_j8YXIw7Gh9EULQ5Dek6eWjMkfHF3rsjXi_Pt2SW9-vzh49nmiralkhNtrNwprmol0aI1rFFKIC93YFVdYtMBb0XJS9ZZpmRVQdW1OyUBre1a2QLAiry97Zv9_JwxTXp0aXmB8RjmpHmt6gZqyNoVef0Peh3mmG1kqgEhFYDgD1RvBtTO2zBF0y5N9aasqlI1rFyo9X-ovDocXZvjsi7XHwne_CXYoxmmfQrDPOWfT4_Bd7dgG0NKEa0-RDeaeKM500v8OkS9xK-X-DP-6s7UvBuxu4f_5P0wOB1ywK4L6Z4JkUJFmaQggcFvDwW1hg |
CitedBy_id | crossref_primary_10_1038_s41419_018_0291_9 crossref_primary_10_1002_jcp_28564 crossref_primary_10_1186_s13148_020_00862_0 crossref_primary_10_1111_jcmm_14579 crossref_primary_10_1002_path_5987 crossref_primary_10_1016_j_bbcan_2024_189082 crossref_primary_10_1016_j_prp_2018_08_005 crossref_primary_10_1111_jcmm_15777 crossref_primary_10_3892_ijo_2019_4880 crossref_primary_10_3390_biomedicines8120637 crossref_primary_10_18632_oncotarget_12928 crossref_primary_10_1016_j_bcp_2023_115594 crossref_primary_10_2217_epi_2020_0186 crossref_primary_10_1016_j_yexcr_2018_10_007 crossref_primary_10_1016_j_neurobiolaging_2018_04_019 crossref_primary_10_18632_oncotarget_19932 crossref_primary_10_1096_fj_201801989R crossref_primary_10_1038_s41598_021_90081_1 |
Cites_doi | 10.1016/j.ccr.2013.04.008 10.1038/sj.onc.1205260 10.1182/blood-2010-03-273441 10.1038/ncomms5255 10.3892/or.2014.3114 10.1046/j.1087-0024.2000.00003.x 10.1161/01.RES.0000259593.07661.1e 10.1242/jcs.125021 10.1038/srep00650 10.2147/vhrm.2006.2.3.213 10.1038/ni.3125 10.1172/JCI70626 10.1038/sj.onc.1206226 10.1200/JCO.2014.60.0759 10.1158/1541-7786.MCR-12-0661 10.1038/cddis.2013.527 10.1016/j.molcel.2012.09.004 10.1371/journal.pone.0095993 10.1053/j.seminoncol.2007.09.009 10.1172/JCI70212 10.1038/nrm909 10.4049/jimmunol.1302943 10.1186/1479-5876-6-53 10.1016/j.cellsig.2013.05.007 10.1038/nrc2403 10.3892/or.2014.2974 10.1038/srep08229 10.1200/JCO.2012.47.3728 10.1038/nm.2575 10.18632/oncotarget.3257 10.1023/A:1010094431748 10.1155/2012/647684 10.1007/978-1-61779-980-8_23 10.1177/1947601911423031 10.1182/blood.V95.1.189 10.1038/nrc1886 10.1038/sj.onc.1204390 |
ContentType | Journal Article |
Copyright | Copyright © 2016, Spandidos Publications COPYRIGHT 2016 Spandidos Publications Copyright Spandidos Publications UK Ltd. 2016 |
Copyright_xml | – notice: Copyright © 2016, Spandidos Publications – notice: COPYRIGHT 2016 Spandidos Publications – notice: Copyright Spandidos Publications UK Ltd. 2016 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AN0 BENPR CCPQU FYUFA GHDGH K9. M0S M1P PQEST PQQKQ PQUKI PRINS 7X8 |
DOI | 10.3892/or.2016.4761 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) ProQuest_Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central British Nursing Database AUTh Library subscriptions: ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) British Nursing Index with Full Text ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest One Academic ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE ProQuest One Academic Eastern Edition MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: 7X7 name: ProQuest_Health & Medical Collection url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1791-2431 |
EndPage | 3638 |
ExternalDocumentID | A455489041 10_3892_or_2016_4761 27109360 or-35-06-3630 |
Genre | Journal Article |
GeographicLocations | United States--US |
GeographicLocations_xml | – name: United States--US |
GroupedDBID | - 0R 123 2WC 3V. 53G 7X7 88E 8FI 8FJ AAPBV AASXA ABPMR ABUWG ACGFS ADBBV AENEX AFKRA AGCAB AHMBA ALMA_UNASSIGNED_HOLDINGS AN0 BAWUL BBAFP BENPR BNQBC BPHCQ BVXVI C45 CS3 DIK E3Z EBD EBS EJD F5P FRP FYUFA GX1 H13 HUR HZ IAO IHR IHW INH INR ITC LI0 M1P O9- OGEVE OK1 OVD PQEST PQQKQ PQUKI PRINS PROAC PSQYO RIG SV3 UDS W2D --- 0R~ ABJNI AEGXH AFOSN ALIPV CCPQU CGR CUY CVF ECM EIF EMOBN HMCUK HZ~ IPNFZ NPM ODZKP TEORI TR2 UKHRP AAYXX CITATION 7XB 8FK K9. 7X8 |
ID | FETCH-LOGICAL-c486t-9f6b818786efefa09882e14b3f874e9d31c24140df0865535dcb863effdc6c333 |
IEDL.DBID | BENPR |
ISSN | 1021-335X |
IngestDate | Tue Aug 27 04:39:21 EDT 2024 Thu Oct 10 14:23:28 EDT 2024 Thu Feb 22 23:57:02 EST 2024 Tue Nov 12 23:25:26 EST 2024 Tue Aug 20 22:07:37 EDT 2024 Fri Aug 23 00:41:27 EDT 2024 Tue Aug 27 13:47:06 EDT 2024 Tue Jan 05 23:28:26 EST 2021 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c486t-9f6b818786efefa09882e14b3f874e9d31c24140df0865535dcb863effdc6c333 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.spandidos-publications.com/10.3892/or.2016.4761/download |
PMID | 27109360 |
PQID | 1932683321 |
PQPubID | 2044953 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_1787937355 proquest_journals_1932683321 gale_infotracmisc_A455489041 gale_infotracacademiconefile_A455489041 gale_healthsolutions_A455489041 crossref_primary_10_3892_or_2016_4761 pubmed_primary_27109360 spandidos_primary_or-35-06-3630 |
PublicationCentury | 2000 |
PublicationDate | 2016-06-01 |
PublicationDateYYYYMMDD | 2016-06-01 |
PublicationDate_xml | – month: 06 year: 2016 text: 2016-06-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Greece |
PublicationPlace_xml | – name: Greece – name: Athens |
PublicationTitle | Oncology reports |
PublicationTitleAlternate | Oncol Rep |
PublicationYear | 2016 |
Publisher | D.A. Spandidos Spandidos Publications Spandidos Publications UK Ltd |
Publisher_xml | – name: D.A. Spandidos – name: Spandidos Publications – name: Spandidos Publications UK Ltd |
References | Orgaz, Pandya, Dalmeida, Karagiannis, Sanchez-Laorden, Viros, Albrengues, Nestle, Ridley, Gaggioli (b29-or-35-06-3630) 2014; 5 Mehlen, Puisieux (b3-or-35-06-3630) 2006; 6 Zhuang (b15-or-35-06-3630) 2013; 25 Lee, Lee, Kim, Kim, Park, Kim, Lee, Kim, Kim, Lee (b20-or-35-06-3630) 2012; 48 Wei, Kuo, Chen, Chou, Lai, Lee, Hsieh (b12-or-35-06-3630) 2003; 22 Zhang, Li, Cornelia, Swisher, Kim (b11-or-35-06-3630) 2012; 2 Nishida, Yano, Nishida, Kamura, Kojiro (b35-or-35-06-3630) 2006; 2 Ellis, Hicklin (b6-or-35-06-3630) 2008; 8 Mora, Buettner, Seigne, Diaz, Ahmad, Garcia, Bowman, Falcone, Fairclough, Cantor (b16-or-35-06-3630) 2002; 62 Schaafhausen, Yang, Centanin, Wittbrodt, Bosserhoff, Fischer, Schartl, Meierjohann (b5-or-35-06-3630) 2013; 126 Yeh, Kim (b9-or-35-06-3630) 2015; 33 Judd, Menheniott, Ling, Jackson, Howlett, Kalantzis, Priebe, Giraud (b32-or-35-06-3630) 2014; 9 Niu, Wright, Huang, Song, Haura, Turkson, Zhang, Wang, Sinibaldi, Coppola (b17-or-35-06-3630) 2002; 21 Tas (b1-or-35-06-3630) 2012; 2012 Caganova, Carrisi, Varano, Mainoldi, Zanardi, Germain, George, Alberghini, Ferrarini, Talukder (b19-or-35-06-3630) 2013; 123 Welti, Loges, Dimmeler, Carmeliet (b7-or-35-06-3630) 2013; 123 Lamalice, Le Boeuf, Huot (b4-or-35-06-3630) 2007; 100 Zhou, Ren, Liu, Han, Zhang, Li, Li, Li, Kang, Wang (b33-or-35-06-3630) 2014; 31 Shibuya (b38-or-35-06-3630) 2011; 2 Kim, Kim, Woo, Shin, Shin, Chang, Oh, Kim, Rheey, Nakano (b23-or-35-06-3630) 2013; 23 Eustace, Crown, Clynes, O'Donovan (b30-or-35-06-3630) 2008; 6 Kimura, Weisz, Kurashima, Hashimoto, Ogura, D'Acquisto, Addeo, Makuuchi, Esumi (b13-or-35-06-3630) 2000; 95 Jia, Hong, Lei, Li, Li, Mo, Wang, Shao, Shen, Cheng (b8-or-35-06-3630) 2015; 6 Levy, Darnell (b14-or-35-06-3630) 2002; 3 Geller, Clapp, Sober, Gonsalves, Mueller, Christiansen, Shaikh, Miller (b2-or-35-06-3630) 2013; 31 Domashenko, Wiener, Emerson (b24-or-35-06-3630) 2012; 916 Cao, Zhou, Zhao, Jin, Yu, Yan, Hu, Guo (b10-or-35-06-3630) 2014; 31 Detmar (b39-or-35-06-3630) 2000; 5 Rao, Dhele, Cheemadan, Ketkar, Jayandharan, Palakodeti, Rampalli (b18-or-35-06-3630) 2015; 5 Jin, Fan, Fan, Zhao, Tong, Blanck, Alomo, Rajasekaran, Zhan (b27-or-35-06-3630) 2001; 20 Matuoka, Chen (b28-or-35-06-3630) 2000; 1 Garipov, Li, Bitler, Thapa, Balachandran, Zhang (b34-or-35-06-3630) 2013; 11 Gunawan, Venkatesan, Loh, Wong, Berger, Neo, Li, La Win, Yau, Guo (b21-or-35-06-3630) 2015; 16 Herraiz, Calvo, Pandya, Cantelli, Rodriguez-Hernandez, Orgaz, Kang, Chu, Sahai, Sanz-Moreno (b31-or-35-06-3630) 2015; 108 Domashenko, Danet-Desnoyers, Aron, Carroll, Emerson (b26-or-35-06-3630) 2010; 116 Xue, Lim, Yang, Wang, Jensen, Hedlund, Andersson, Sasahara, Larsson, Galter (b36-or-35-06-3630) 2011; 18 Lin, Chen, Lin, Wang, Chou, Chen (b25-or-35-06-3630) 2014; 5 Tong, He, Xie, Mochizuki, Liu, Mochizuki, Meng, Sun, Zhang, Guo (b22-or-35-06-3630) 2014; 192 Mahabeleshwar, Byzova (b37-or-35-06-3630) 2007; 34 Caganova (key20180107211635_b19-or-35-06-3630) 2013; 123 Mehlen (key20180107211635_b3-or-35-06-3630) 2006; 6 Xue (key20180107211635_b36-or-35-06-3630) 2011; 18 Geller (key20180107211635_b2-or-35-06-3630) 2013; 31 Schaafhausen (key20180107211635_b5-or-35-06-3630) 2013; 126 Levy (key20180107211635_b14-or-35-06-3630) 2002; 3 Herraiz (key20180107211635_b31-or-35-06-3630) 2015; 108 Lamalice (key20180107211635_b4-or-35-06-3630) 2007; 100 Ellis (key20180107211635_b6-or-35-06-3630) 2008; 8 Judd (key20180107211635_b32-or-35-06-3630) 2014; 9 Tas (key20180107211635_b1-or-35-06-3630) 2012; 2012 Zhuang (key20180107211635_b15-or-35-06-3630) 2013; 25 Kim (key20180107211635_b23-or-35-06-3630) 2013; 23 Domashenko (key20180107211635_b26-or-35-06-3630) 2010; 116 Eustace (key20180107211635_b30-or-35-06-3630) 2008; 6 Shibuya (key20180107211635_b38-or-35-06-3630) 2011; 2 Garipov (key20180107211635_b34-or-35-06-3630) 2013; 11 Niu (key20180107211635_b17-or-35-06-3630) 2002; 21 Jia (key20180107211635_b8-or-35-06-3630) 2015; 6 Orgaz (key20180107211635_b29-or-35-06-3630) 2014; 5 Mahabeleshwar (key20180107211635_b37-or-35-06-3630) 2007; 34 Nishida (key20180107211635_b35-or-35-06-3630) 2006; 2 Lee (key20180107211635_b20-or-35-06-3630) 2012; 48 Jin (key20180107211635_b27-or-35-06-3630) 2001; 20 Rao (key20180107211635_b18-or-35-06-3630) 2015; 5 Detmar (key20180107211635_b39-or-35-06-3630) 2000; 5 Yeh (key20180107211635_b9-or-35-06-3630) 2015; 33 Domashenko (key20180107211635_b24-or-35-06-3630) 2012; 916 Wei (key20180107211635_b12-or-35-06-3630) 2003; 22 Welti (key20180107211635_b7-or-35-06-3630) 2013; 123 Mora (key20180107211635_b16-or-35-06-3630) 2002; 62 Tong (key20180107211635_b22-or-35-06-3630) 2014; 192 Lin (key20180107211635_b25-or-35-06-3630) 2014; 5 Cao (key20180107211635_b10-or-35-06-3630) 2014; 31 Zhang (key20180107211635_b11-or-35-06-3630) 2012; 2 Kimura (key20180107211635_b13-or-35-06-3630) 2000; 95 Matuoka (key20180107211635_b28-or-35-06-3630) 2000; 1 Zhou (key20180107211635_b33-or-35-06-3630) 2014; 31 Gunawan (key20180107211635_b21-or-35-06-3630) 2015; 16 |
References_xml | – volume: 31 start-page: 417 year: 2013 end-page: 4178 ident: b2-or-35-06-3630 article-title: Melanoma epidemic: An analysis of six decades of data from the Connecticut Tumor Registry publication-title: J Clin Oncol contributor: fullname: Miller – volume: 916 start-page: 303 year: 2012 end-page: 316 ident: b24-or-35-06-3630 article-title: NF-Ya protein delivery as a tool for hematopoietic progenitor cell expansion publication-title: Methods Mol Biol contributor: fullname: Emerson – volume: 18 start-page: 100 year: 2011 end-page: 110 ident: b36-or-35-06-3630 article-title: PDGF-BB modulates hematopoiesis and tumor angiogenesis by inducing erythropoietin production in stromal cells publication-title: Nat Med contributor: fullname: Galter – volume: 123 start-page: 5009 year: 2013 end-page: 5022 ident: b19-or-35-06-3630 article-title: Germinal center dysregulation by histone methyltransferase EZH2 promotes lymphomagenesis publication-title: J Clin Invest contributor: fullname: Talukder – volume: 5 start-page: 20 year: 2000 end-page: 23 ident: b39-or-35-06-3630 article-title: Tumor angiogenesis publication-title: J Investig Dermatol Symp Proc contributor: fullname: Detmar – volume: 6 start-page: 449 year: 2006 end-page: 458 ident: b3-or-35-06-3630 article-title: Metastasis: A question of life or death publication-title: Nat Rev Cancer contributor: fullname: Puisieux – volume: 116 start-page: 2676 year: 2010 end-page: 2683 ident: b26-or-35-06-3630 article-title: TAT-mediated transduction of NF-Ya peptide induces the ex vivo proliferation and engraftment potential of human hematopoietic progenitor cells publication-title: Blood contributor: fullname: Emerson – volume: 2 start-page: 650 year: 2012 ident: b11-or-35-06-3630 article-title: Regulation of VEGF expression by HIF-1α in the femoral head cartilage following ischemia osteonecrosis publication-title: Sci Rep contributor: fullname: Kim – volume: 8 start-page: 579 year: 2008 end-page: 591 ident: b6-or-35-06-3630 article-title: VEGF-targeted therapy: Mechanisms of anti-tumour activity publication-title: Nat Rev Cancer contributor: fullname: Hicklin – volume: 95 start-page: 189 year: 2000 end-page: 197 ident: b13-or-35-06-3630 article-title: Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: Control of hypoxia-inducible factor-1 activity by nitric oxide publication-title: Blood contributor: fullname: Esumi – volume: 23 start-page: 839 year: 2013 end-page: 852 ident: b23-or-35-06-3630 article-title: Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells publication-title: Cancer Cell contributor: fullname: Nakano – volume: 100 start-page: 782 year: 2007 end-page: 794 ident: b4-or-35-06-3630 article-title: Endothelial cell migration during angiogenesis publication-title: Circ Res contributor: fullname: Huot – volume: 2 start-page: 1097 year: 2011 end-page: 1105 ident: b38-or-35-06-3630 article-title: Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: A crucial target for anti- and proangiogenic therapies publication-title: Genes Cancer contributor: fullname: Shibuya – volume: 1 start-page: 261 year: 2000 end-page: 271 ident: b28-or-35-06-3630 article-title: Possible role of subunit A of nuclear factor Y (NF-YA) in normal human diploid fibroblasts during senescence publication-title: Biogerontology contributor: fullname: Chen – volume: 21 start-page: 2000 year: 2002 end-page: 2008 ident: b17-or-35-06-3630 article-title: Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis publication-title: Oncogene contributor: fullname: Coppola – volume: 11 start-page: 360 year: 2013 end-page: 369 ident: b34-or-35-06-3630 article-title: NF-YA underlies EZH2 upregulation and is essential for proliferation of human epithelial ovarian cancer cells publication-title: Mol Cancer Res contributor: fullname: Zhang – volume: 108 year: 2015 ident: b31-or-35-06-3630 article-title: Reactivation of p53 by a cytoskeletal sensor to control the balance between DNA damage and tumor dissemination publication-title: J Natl Cancer Inst contributor: fullname: Sanz-Moreno – volume: 2 start-page: 213 year: 2006 end-page: 219 ident: b35-or-35-06-3630 article-title: Angiogenesis in cancer publication-title: Vasc Health Risk Manag contributor: fullname: Kojiro – volume: 126 start-page: 3862 year: 2013 end-page: 3872 ident: b5-or-35-06-3630 article-title: Tumor angiogenesis is caused by single melanoma cells in a manner dependent on reactive oxygen species and NF-κB publication-title: J Cell Sci contributor: fullname: Meierjohann – volume: 33 start-page: 1505 year: 2015 end-page: 1508 ident: b9-or-35-06-3630 article-title: Targeting tumor hypoxia with hypoxia-activated prodrugs publication-title: J Clin Oncol contributor: fullname: Kim – volume: 5 start-page: e987 year: 2014 ident: b25-or-35-06-3630 article-title: Association of p21 with NF-YA suppresses the expression of Polo-like kinase 1 and prevents mitotic death in response to DNA damage publication-title: Cell Death Dis contributor: fullname: Chen – volume: 62 start-page: 6659 year: 2002 end-page: 6666 ident: b16-or-35-06-3630 article-title: Constitutive activation of Stat3 in human prostate tumors and cell lines: Direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells publication-title: Cancer Res contributor: fullname: Cantor – volume: 2012 start-page: 647684 year: 2012 ident: b1-or-35-06-3630 article-title: Metastatic behavior in melanoma: Timing, pattern, survival, and influencing factors publication-title: J Oncol contributor: fullname: Tas – volume: 34 start-page: 555 year: 2007 end-page: 565 ident: b37-or-35-06-3630 article-title: Angiogenesis in melanoma publication-title: Semin Oncol contributor: fullname: Byzova – volume: 31 start-page: 1205 year: 2014 end-page: 1210 ident: b10-or-35-06-3630 article-title: PGC-1α integrates glucose metabolism and angiogenesis in multiple myeloma cells by regulating VEGF and GLUT-4 publication-title: Oncol Rep contributor: fullname: Guo – volume: 5 start-page: 4255 year: 2014 ident: b29-or-35-06-3630 article-title: Diverse matrix metalloproteinase functions regulate cancer amoeboid migration publication-title: Nat Commun contributor: fullname: Gaggioli – volume: 123 start-page: 3190 year: 2013 end-page: 3200 ident: b7-or-35-06-3630 article-title: Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer publication-title: J Clin Invest contributor: fullname: Carmeliet – volume: 20 start-page: 2683 year: 2001 end-page: 2690 ident: b27-or-35-06-3630 article-title: Transcription factors Oct-1 and NF-YA regulate the p53-independent induction of the GADD45 following DNA damage publication-title: Oncogene contributor: fullname: Zhan – volume: 3 start-page: 651 year: 2002 end-page: 662 ident: b14-or-35-06-3630 article-title: Stats: Transcriptional control and biological impact publication-title: Nat Rev Mol Cell Biol contributor: fullname: Darnell – volume: 48 start-page: 572 year: 2012 end-page: 586 ident: b20-or-35-06-3630 article-title: EZH2 generates a methyl degron that is recognized by the DCAF1/DDB1/CUL4 E3 ubiquitin ligase complex publication-title: Mol Cell contributor: fullname: Lee – volume: 22 start-page: 1517 year: 2003 end-page: 1527 ident: b12-or-35-06-3630 article-title: Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway publication-title: Oncogene contributor: fullname: Hsieh – volume: 9 start-page: e95993 year: 2014 ident: b32-or-35-06-3630 article-title: Inhibition of the JAK2/STAT3 pathway reduces gastric cancer growth in vitro and in vivo publication-title: PLoS One contributor: fullname: Giraud – volume: 6 start-page: 8648 year: 2015 end-page: 8662 ident: b8-or-35-06-3630 article-title: Basal and therapy-driven hypoxia-inducible factor-1α confers resistance to endocrine therapy in estrogen receptor-positive breast cancer publication-title: Oncotarget contributor: fullname: Cheng – volume: 25 start-page: 1924 year: 2013 end-page: 1931 ident: b15-or-35-06-3630 article-title: Regulation of STAT signaling by acetylation publication-title: Cell Signal contributor: fullname: Zhuang – volume: 192 start-page: 5012 year: 2014 end-page: 5022 ident: b22-or-35-06-3630 article-title: Ezh2 regulates transcriptional and posttranslational expression of T-bet and promotes Th1 cell responses mediating aplastic anemia in mice publication-title: J Immunol contributor: fullname: Guo – volume: 5 start-page: 8229 year: 2015 ident: b18-or-35-06-3630 article-title: Ezh2 mediated H3K27me3 activity facilitates somatic transition during human pluripotent reprogramming publication-title: Sci Rep contributor: fullname: Rampalli – volume: 16 start-page: 505 year: 2015 end-page: 516 ident: b21-or-35-06-3630 article-title: The methyltransferase Ezh2 controls cell adhesion and migration through direct methylation of the extranuclear regulatory protein talin publication-title: Nat Immunol contributor: fullname: Guo – volume: 31 start-page: 2173 year: 2014 end-page: 2180 ident: b33-or-35-06-3630 article-title: STAT3 inhibitor WP1066 attenuates miRNA-21 to suppress human oral squamous cell carcinoma growth in vitro and in vivo publication-title: Oncol Rep contributor: fullname: Wang – volume: 6 start-page: 53 year: 2008 ident: b30-or-35-06-3630 article-title: Preclinical evaluation of dasatinib, a potent Src kinase inhibitor, in melanoma cell lines publication-title: J Transl Med contributor: fullname: O'Donovan – volume: 23 start-page: 839 year: 2013 ident: key20180107211635_b23-or-35-06-3630 article-title: Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells publication-title: Cancer Cell doi: 10.1016/j.ccr.2013.04.008 contributor: fullname: Kim – volume: 21 start-page: 2000 year: 2002 ident: key20180107211635_b17-or-35-06-3630 article-title: Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis publication-title: Oncogene doi: 10.1038/sj.onc.1205260 contributor: fullname: Niu – volume: 116 start-page: 2676 year: 2010 ident: key20180107211635_b26-or-35-06-3630 article-title: TAT-mediated transduction of NF-Ya peptide induces the ex vivo proliferation and engraftment potential of human hematopoietic progenitor cells publication-title: Blood doi: 10.1182/blood-2010-03-273441 contributor: fullname: Domashenko – volume: 62 start-page: 6659 year: 2002 ident: key20180107211635_b16-or-35-06-3630 article-title: Constitutive activation of Stat3 in human prostate tumors and cell lines: Direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells publication-title: Cancer Res contributor: fullname: Mora – volume: 5 start-page: 4255 year: 2014 ident: key20180107211635_b29-or-35-06-3630 article-title: Diverse matrix metalloproteinase functions regulate cancer amoeboid migration publication-title: Nat Commun doi: 10.1038/ncomms5255 contributor: fullname: Orgaz – volume: 31 start-page: 2173 year: 2014 ident: key20180107211635_b33-or-35-06-3630 article-title: STAT3 inhibitor WP1066 attenuates miRNA-21 to suppress human oral squamous cell carcinoma growth in vitro and in vivo publication-title: Oncol Rep doi: 10.3892/or.2014.3114 contributor: fullname: Zhou – volume: 5 start-page: 20 year: 2000 ident: key20180107211635_b39-or-35-06-3630 article-title: Tumor angiogenesis publication-title: J Investig Dermatol Symp Proc doi: 10.1046/j.1087-0024.2000.00003.x contributor: fullname: Detmar – volume: 100 start-page: 782 year: 2007 ident: key20180107211635_b4-or-35-06-3630 article-title: Endothelial cell migration during angiogenesis publication-title: Circ Res doi: 10.1161/01.RES.0000259593.07661.1e contributor: fullname: Lamalice – volume: 126 start-page: 3862 year: 2013 ident: key20180107211635_b5-or-35-06-3630 article-title: Tumor angiogenesis is caused by single melanoma cells in a manner dependent on reactive oxygen species and NF-κB publication-title: J Cell Sci doi: 10.1242/jcs.125021 contributor: fullname: Schaafhausen – volume: 2 start-page: 650 year: 2012 ident: key20180107211635_b11-or-35-06-3630 article-title: Regulation of VEGF expression by HIF-1α in the femoral head cartilage following ischemia osteonecrosis publication-title: Sci Rep doi: 10.1038/srep00650 contributor: fullname: Zhang – volume: 108 year: 2015 ident: key20180107211635_b31-or-35-06-3630 article-title: Reactivation of p53 by a cytoskeletal sensor to control the balance between DNA damage and tumor dissemination publication-title: J Natl Cancer Inst contributor: fullname: Herraiz – volume: 2 start-page: 213 year: 2006 ident: key20180107211635_b35-or-35-06-3630 article-title: Angiogenesis in cancer publication-title: Vasc Health Risk Manag doi: 10.2147/vhrm.2006.2.3.213 contributor: fullname: Nishida – volume: 16 start-page: 505 year: 2015 ident: key20180107211635_b21-or-35-06-3630 article-title: The methyltransferase Ezh2 controls cell adhesion and migration through direct methylation of the extranuclear regulatory protein talin publication-title: Nat Immunol doi: 10.1038/ni.3125 contributor: fullname: Gunawan – volume: 123 start-page: 5009 year: 2013 ident: key20180107211635_b19-or-35-06-3630 article-title: Germinal center dysregulation by histone methyltransferase EZH2 promotes lymphomagenesis publication-title: J Clin Invest doi: 10.1172/JCI70626 contributor: fullname: Caganova – volume: 22 start-page: 1517 year: 2003 ident: key20180107211635_b12-or-35-06-3630 article-title: Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway publication-title: Oncogene doi: 10.1038/sj.onc.1206226 contributor: fullname: Wei – volume: 33 start-page: 1505 year: 2015 ident: key20180107211635_b9-or-35-06-3630 article-title: Targeting tumor hypoxia with hypoxia-activated prodrugs publication-title: J Clin Oncol doi: 10.1200/JCO.2014.60.0759 contributor: fullname: Yeh – volume: 11 start-page: 360 year: 2013 ident: key20180107211635_b34-or-35-06-3630 article-title: NF-YA underlies EZH2 upregulation and is essential for proliferation of human epithelial ovarian cancer cells publication-title: Mol Cancer Res doi: 10.1158/1541-7786.MCR-12-0661 contributor: fullname: Garipov – volume: 5 start-page: e987 year: 2014 ident: key20180107211635_b25-or-35-06-3630 article-title: Association of p21 with NF-YA suppresses the expression of Polo-like kinase 1 and prevents mitotic death in response to DNA damage publication-title: Cell Death Dis doi: 10.1038/cddis.2013.527 contributor: fullname: Lin – volume: 48 start-page: 572 year: 2012 ident: key20180107211635_b20-or-35-06-3630 article-title: EZH2 generates a methyl degron that is recognized by the DCAF1/DDB1/CUL4 E3 ubiquitin ligase complex publication-title: Mol Cell doi: 10.1016/j.molcel.2012.09.004 contributor: fullname: Lee – volume: 9 start-page: e95993 year: 2014 ident: key20180107211635_b32-or-35-06-3630 article-title: Inhibition of the JAK2/STAT3 pathway reduces gastric cancer growth in vitro and in vivo publication-title: PLoS One doi: 10.1371/journal.pone.0095993 contributor: fullname: Judd – volume: 34 start-page: 555 year: 2007 ident: key20180107211635_b37-or-35-06-3630 article-title: Angiogenesis in melanoma publication-title: Semin Oncol doi: 10.1053/j.seminoncol.2007.09.009 contributor: fullname: Mahabeleshwar – volume: 123 start-page: 3190 year: 2013 ident: key20180107211635_b7-or-35-06-3630 article-title: Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer publication-title: J Clin Invest doi: 10.1172/JCI70212 contributor: fullname: Welti – volume: 3 start-page: 651 year: 2002 ident: key20180107211635_b14-or-35-06-3630 article-title: Stats: Transcriptional control and biological impact publication-title: Nat Rev Mol Cell Biol doi: 10.1038/nrm909 contributor: fullname: Levy – volume: 192 start-page: 5012 year: 2014 ident: key20180107211635_b22-or-35-06-3630 article-title: Ezh2 regulates transcriptional and posttranslational expression of T-bet and promotes Th1 cell responses mediating aplastic anemia in mice publication-title: J Immunol doi: 10.4049/jimmunol.1302943 contributor: fullname: Tong – volume: 6 start-page: 53 year: 2008 ident: key20180107211635_b30-or-35-06-3630 article-title: Preclinical evaluation of dasatinib, a potent Src kinase inhibitor, in melanoma cell lines publication-title: J Transl Med doi: 10.1186/1479-5876-6-53 contributor: fullname: Eustace – volume: 25 start-page: 1924 year: 2013 ident: key20180107211635_b15-or-35-06-3630 article-title: Regulation of STAT signaling by acetylation publication-title: Cell Signal doi: 10.1016/j.cellsig.2013.05.007 contributor: fullname: Zhuang – volume: 8 start-page: 579 year: 2008 ident: key20180107211635_b6-or-35-06-3630 article-title: VEGF-targeted therapy: Mechanisms of anti-tumour activity publication-title: Nat Rev Cancer doi: 10.1038/nrc2403 contributor: fullname: Ellis – volume: 31 start-page: 1205 year: 2014 ident: key20180107211635_b10-or-35-06-3630 article-title: PGC-1α integrates glucose metabolism and angiogenesis in multiple myeloma cells by regulating VEGF and GLUT-4 publication-title: Oncol Rep doi: 10.3892/or.2014.2974 contributor: fullname: Cao – volume: 5 start-page: 8229 year: 2015 ident: key20180107211635_b18-or-35-06-3630 article-title: Ezh2 mediated H3K27me3 activity facilitates somatic transition during human pluripotent reprogramming publication-title: Sci Rep doi: 10.1038/srep08229 contributor: fullname: Rao – volume: 31 start-page: 417 year: 2013 ident: key20180107211635_b2-or-35-06-3630 article-title: Melanoma epidemic: An analysis of six decades of data from the Connecticut Tumor Registry publication-title: J Clin Oncol doi: 10.1200/JCO.2012.47.3728 contributor: fullname: Geller – volume: 18 start-page: 100 year: 2011 ident: key20180107211635_b36-or-35-06-3630 article-title: PDGF-BB modulates hematopoiesis and tumor angiogenesis by inducing erythropoietin production in stromal cells publication-title: Nat Med doi: 10.1038/nm.2575 contributor: fullname: Xue – volume: 6 start-page: 8648 year: 2015 ident: key20180107211635_b8-or-35-06-3630 article-title: Basal and therapy-driven hypoxia-inducible factor-1α confers resistance to endocrine therapy in estrogen receptor-positive breast cancer publication-title: Oncotarget doi: 10.18632/oncotarget.3257 contributor: fullname: Jia – volume: 1 start-page: 261 year: 2000 ident: key20180107211635_b28-or-35-06-3630 article-title: Possible role of subunit A of nuclear factor Y (NF-YA) in normal human diploid fibroblasts during senescence publication-title: Biogerontology doi: 10.1023/A:1010094431748 contributor: fullname: Matuoka – volume: 2012 start-page: 647684 year: 2012 ident: key20180107211635_b1-or-35-06-3630 article-title: Metastatic behavior in melanoma: Timing, pattern, survival, and influencing factors publication-title: J Oncol doi: 10.1155/2012/647684 contributor: fullname: Tas – volume: 916 start-page: 303 year: 2012 ident: key20180107211635_b24-or-35-06-3630 article-title: NF-Ya protein delivery as a tool for hematopoietic progenitor cell expansion publication-title: Methods Mol Biol doi: 10.1007/978-1-61779-980-8_23 contributor: fullname: Domashenko – volume: 2 start-page: 1097 year: 2011 ident: key20180107211635_b38-or-35-06-3630 article-title: Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: A crucial target for anti- and proangiogenic therapies publication-title: Genes Cancer doi: 10.1177/1947601911423031 contributor: fullname: Shibuya – volume: 95 start-page: 189 year: 2000 ident: key20180107211635_b13-or-35-06-3630 article-title: Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: Control of hypoxia-inducible factor-1 activity by nitric oxide publication-title: Blood doi: 10.1182/blood.V95.1.189 contributor: fullname: Kimura – volume: 6 start-page: 449 year: 2006 ident: key20180107211635_b3-or-35-06-3630 article-title: Metastasis: A question of life or death publication-title: Nat Rev Cancer doi: 10.1038/nrc1886 contributor: fullname: Mehlen – volume: 20 start-page: 2683 year: 2001 ident: key20180107211635_b27-or-35-06-3630 article-title: Transcription factors Oct-1 and NF-YA regulate the p53-independent induction of the GADD45 following DNA damage publication-title: Oncogene doi: 10.1038/sj.onc.1204390 contributor: fullname: Jin |
SSID | ssj0027069 |
Score | 2.2828863 |
Snippet | The process of angiogenesis is essential for tumor development and metastasis. Vascular endothelial growth factor (VEGF), which is overexpressed in most human... |
SourceID | proquest gale crossref pubmed spandidos |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 3630 |
SubjectTerms | Angiogenesis CCAAT-Binding Factor - metabolism Cell adhesion & migration Cell Line, Tumor Cellular signal transduction Chemotherapy Cytokines Development and progression enhancer of zeste homolog 2 Enhancer of Zeste Homolog 2 Protein - metabolism Gene expression Genetic aspects Health aspects HEK293 Cells Human Umbilical Vein Endothelial Cells Humans Hypoxia Melanoma Melanoma - pathology Methods Methylation Molecular targeted therapy Neoplasm Invasiveness - pathology Neovascularization, Pathologic - pathology nuclear transcription factor-Y alpha Phosphorylation Plasmids Properties Proteins Signal Transduction STAT3 STAT3 Transcription Factor - metabolism Transcription factors Vascular endothelial growth factor Vascular Endothelial Growth Factor A - metabolism Vascular Endothelial Growth Factor A - secretion |
Title | NF-YA promotes invasion and angiogenesis by upregulating EZH2-STAT3 signaling in human melanoma cells |
URI | https://www.ncbi.nlm.nih.gov/pubmed/27109360 https://www.proquest.com/docview/1932683321 https://search.proquest.com/docview/1787937355 |
Volume | 35 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR3LjtMw0GK7EnBBvCksi5FAnMw6seMkJ1RQqwppKwRdqXCJ_FxVYpOStEj8PTNJmt1y4JCTx0k8nrdnPIS8cdakVlvOTBw7JsG9ZiaKNLgqiVTBGc_bi-fPF2p-IT-vklUfcGv6tMq9TGwFtassxsjPWkMjEyKOPmx-MewahaerfQuNI3Icg6fAR-T443Tx5eu1y8XbpnbYv5oJkay61HdQ0vFZhbeBRuq9TFV0oJT-Fc03dNMd4PLSrV3V3FBCs_vkXm890km33Q_ILV8-JLfP-_PxR8QvZuz7hG7aHDvf0HX5W2M4jML74LlcV5co29YNNX_oblN3jehBe9Hpj3nMvi0nS0ExpUNjlTpMp20PP3rlf-qyutIU4_zNY3Ixmy4_zVnfSIFZmakty4MyoJjTTPngg-Y5mNU-kkaELJU-dyKyoMgld4FjnapIYAczJXwIziorhHhCRmVV-meE2kSbLA9JrgzYIjzV0gSvdMi0j7lL8jF5u8dksenuyyjAz0CMF1VdIMYLxPiYvEI0F12158BmxUSCfZPlXALEuxYCGW1bayCorl4A_gOvrDqAPDmABAaxh8P7rSx6Bm2Ka3Iak9fDMM7EpLPSVzuAAWEG1htYZGPytCOBYU0x5rAKxWEdA00Mg1XNRNImFSrBn___8y_IXURKl312Qkbbeudfgp2zNafkKF2lpz1J_wW0nPqY |
link.rule.ids | 315,783,787,12068,21400,27936,27937,31731,31732,33756,33757,43322,43817,74073,74630 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1db9Mw0IJNYrwgvikMZiQQT2ZO7DjJEyqoVYG1QtBJhRfLduypEktK0iLx77lL0m7lgYc8-ZzE5_v2-Y6QV4WzqTOOMxvHBZPgXjMbRQZclUSqUFjP28Lz05manMtPi2TRB9yaPq1yKxNbQV1UDmPkp62hkQkRR-9Wvxh2jcLT1b6Fxk1yiKWqwPk6fD-affl65XLxtqkd9q9mQiSLLvUdlHR8WmE10Ei9lamK9pTSv6L5mm46Ai4vi2VRNdeU0PguudNbj3TYbfc9csOX98mtaX8-_oD42Zh9H9JVm2PnG7osfxsMh1F4HzwXy-oCZduyofYP3azqrhE9aC86-jGJ2bf5cC4opnQYvKUO02nbw49e-p-mrC4NxTh_85Ccj0fzDxPWN1JgTmZqzfKgLCjmNFM--GB4Dma1j6QVIUulzwsROVDkkheB4z1VkcAOZkr4EAqnnBDiETkoq9I_IdQlxmZ5SHJlwRbhqZE2eGVCZnzMiyQfkNdbTOpVVy9Dg5-BGNdVrRHjGjE-ICeIZt3d9tyxmR5KsG-ynEuAeNNCIKOtawME1d0XgP_AklV7kMd7kMAgbn94u5W6Z9BGX5HTgLzcDeNMTDorfbUBGBBmYL2BRTYgjzsS2K0pxhxWoTisY0cTu8GqZiJpkwqV4E____kTcjSZT8_02cfZ52fkNiKoy0Q7JgfreuOfg82zti96wv4L3LX8qw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3Nb9MwFLegkwYXxDeFwYwE4mTqxI6TnFCBVuVj1QSdVHaJ7NieKrGkJC0S_z3vJWm2cuCQk5-T-Pl92j_7EfLK5ibOdc6ZCUPLJKTXzASBhlQlkspb43hz8fzJXM3O5OdltOzwT3UHq9zZxMZQ2zLHNfJRE2gkQoTByHewiNOP03frXwwrSOFOa1dO4yY5iKUSfEAO3k_mp9-u0i_eFLjDWtZMiGjZwuDBYYejEm8GDdRbGatgz0H9a6av-alboPGFXdmyvuaQpnfJnS6SpON26u-RG664Tw5Pur3yB8TNp-zHmK4bvJ2r6ar4rXFpjML74LlYlRdo51Y1NX_odl21RenBk9HJ-Sxk3xfjhaAI79B4Yh2606aeH710P3VRXmqKa_71Q3I2nSw-zFhXVIHlMlEblnplwEnHiXLeec1TCLFdII3wSSxdakWQg1OX3HqOZ1ZFBLOZKOG8t7nKhRCPyKAoC_eE0DzSJkl9lCoDcQmPtTTeKe0T7UJuo3RIXu84ma3buzMyyDmQ41lZZcjxDDk-JMfI5qw9-dmrXDaWEOskKZdA8aahQKXbVBqEqz07AP-B11ftUR7tUYKy5PvNu6nMOmWtsyvRGpKXfTP2RABa4cot0IBhg0gOorMhedyKQD-mEPGsQnEYRy8TfWNZMRE1AEOQyaf___wxOQSZzr5-mn95Rm4jf1pQ2hEZbKqtew7hz8a86OT6L84rAOg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=NF-YA+promotes+invasion+and+angiogenesis+by+upregulating+EZH2-STAT3+signaling+in+human+melanoma+cells&rft.jtitle=Oncology+reports&rft.au=XU%2C+ZIHAN&rft.au=SUN%2C+YAOWEN&rft.au=GUO%2C+YADONG&rft.au=QIN%2C+GAOPING&rft.date=2016-06-01&rft.pub=Spandidos+Publications+UK+Ltd&rft.issn=1021-335X&rft.eissn=1791-2431&rft.volume=35&rft.issue=6&rft.spage=3630&rft.epage=3638&rft_id=info:doi/10.3892%2For.2016.4761&rft.externalDBID=HAS_PDF_LINK |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1021-335X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1021-335X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1021-335X&client=summon |